Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Oscient steps up antibiotic sales efforts
The 250-person sales team will call on primary care physicians who account for 40% of fluoroquinolone prescriptions written for respiratory tract infections across the US. The sales force
The 250-person sales team will call on primary care physicians who account for 40% of fluoroquinolone prescriptions written for respiratory tract infections across the US. The sales force
The program is intended to determine, in preclinical studies, the potential of skeletally targeted proteasome inhibitors as an effective and selective treatment for myeloma. Proteasome inhibitors have been
In February 2004, Dynavax and Belgium-based UCB Farchim SA, a subsidiary of UCB SA, established a strategic partnering agreement for the development and commercialization of seasonal allergy products.
According to reports, a three-month 12-patient study conducted in Texas, which is to be published in the international medical journal Cancer Letters, revealed that children taking the ADHD
The patents cover valuable vaccine components, such as the Ebola antigens and vectors. The license also covers ‘one-shot’ emergency vaccination strategies that have proven to be effective in
This data was presented via a poster session at the 229th Annual Meeting of the American Chemical Society, in San Diego, California. NeoPharm’s poster described synthesis of gemcitabine-cardiolipin
The goal of the research performed by TorreyPines Therapeutics will be to discover novel Alzheimer’s disease modifying agents based on the study of the mechanism of the disease’s
The purpose of the study was to evaluate the potential additive effect of treating erectile dysfunction (ED) patients with both PT-141, which initiates erections via a central nervous
The randomized, controlled clinical trial, which has enrolled more than 460 patients in Europe, Australia and Canada, is evaluating best supportive care plus panitumumab monotherapy administered every other
The researchers found that a fragment of collagen VII is required for the skin cancer cells to break free from the neighboring skin tissue and spread – a